biomarkers

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

biomarkers
Aug 26, 2024, 20:57 | Blog
The pivotal role of biomarkers in developing targeted cancer therapies - Quest Diagnostics BioPharma Services
Quest Diagnostics BioPharma Services shared a post on LinkedIn: "The role of diagnostic labs in…
Aug 16, 2024, 13:56 | Career
Michael Korn has joined Biocartis NV as its Chief Medical and Scientific Officer
Michael Korn shared a post on LinkedIn: "With great excitement, I have joined Biocartis NV,…
Aug 14, 2024, 13:00 | Insight
Elisa Agostinetto: Immunotherapy has reshaped the cancer treatment paradigm
Elisa Agostinetto shared on X: “Immunotherapy has reshaped cancer treatment paradigm, but we still need…
Aug 10, 2024, 13:49 | Dialogues
Powerful conversation about the mission of Debbie’s Dream Foundation
Debbie's Dream Foundation: Curing Stomach Cancer shared on LinkedIn: "New Interview Alert! Our CEO, Andrea…
Jul 27, 2024, 13:45 | Insight
Italo Fernandes: The role of cell-free DNA for comprehensive genomic analysis in endometrial cancer patients
Italo Fernandes, Medical Oncology Fellow at Sunnybrook Hospital, shared a post on LinkedIn: “Happy to…
Jul 14, 2024, 15:02 | Insight
Bruno Giotti: Multiple gene programs and cellular subpopulations associated with patient prognosis in pleural mesothelioma
Bruno Giotti, Postdoctoral Researcher at Icahn School of Medicine at Mount Sinai, shared a post…
Jul 11, 2024, 13:51 | Blog
Christian Rolfo: Important meeting on Drug Tolerance and Resistance in NSCLC
Christian Rolfo, Associate Director of Clinical Research Center of Thoracic Oncology at The Tisch Cancer…
Jul 6, 2024, 02:00 | Blog
The NCI PREVENT Cancer Preclinical Drug Development Program - NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared on LinkedIn: “Application deadline Monday! Are you someone actively…
Jul 4, 2024, 12:15 | Blog
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…
Jul 2, 2024, 12:04 | Career
Luca Arecco was awarded the ASCO Conquer Cancer Merit Award
Matteo Lambertini shared a post by San Martino Hospital, Genova on X, adding: “Congrats Luca Arecco…
Jul 1, 2024, 17:27 | Blog
Bernard A. Fox: A new generation of immunotherapy clinical trials
Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “Great to be in…
Jun 30, 2024, 12:25 | Societies
The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity
Paola Alberti, Assistant Professor of Human Anatomy at the University of Milano-Bicocca, shared on LinkedIn:…
Jun 27, 2024, 03:46 | Blog
Submit your abstract for the Molecular Analysis for Precision Oncology Congress 2024 in London - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “Submit your abstract for the…
Jun 18, 2024, 06:07 | Blog
Monica Bertagnolli: Insights into Molecular Basis of PTSD and Major Depression Could One Day Aid in Diagnosis and Treatment
Monica Bertagnolli shared on LinkedIn: “We know stress can take a toll on our mental health.…
Jun 14, 2024, 03:24 | Blog
Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X: “PI3K/Akt-targeted agents entered…
Jun 8, 2024, 16:06 | Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 7, 2024, 11:58 | Blog
Yüksel Ürün: Tumor-agnostic therapies are revolutionizing oncology
Yüksel Ürün shared on X:            . "Tumor-agnostic therapies are revolutionizing…
Jun 6, 2024, 09:05 | Blog
ASCO24 trials summarized by Arndt Vogel
Arndt Vogel shared on X/Twitter: "NIVO + IPI vs LEN (90%) or SORA as 1st line…
May 22, 2024, 11:01 | Blog
Josh Atkins: Identifying Proteomic Risk Factors
Josh Atkins, Senior Cancer Genomic Epidemiologist at the Nuffield Department of Population Health of Oxford…
May 11, 2024, 10:58 | Blog
The first edition of the I.N.N.O.V.A.T.E - Neoadjuvant immunotherapy across cancers - 3P Solutions
3P Solution shared a post on LinkedIn: “REGISTRATION IS NOW OPEN! The first edition of the…
May 2, 2024, 08:36 | Insight
Chadi Hage Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 14, 2024, 07:35 | Drugs
Charles Swanton: What is the role of the TME in lung cancer evolution?
Charles Swanton, Professor at University College London Cancer Institute, shared on X/Twitter: "What is the role…
Apr 8, 2024, 22:27 | Insight
Adjuvant Therapy for Urothelial Cancer in Advances in Oncology - New Paper Alert!
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions   Authors: Charbel Hobeika,…
Apr 8, 2024, 15:49 | Insight
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X: "The TRAIN3…
Mar 25, 2024, 06:01 | Insight
Vivek Subbiah: For patients with NSCLC, initial use of SGT increases subsequent CGP test cancellations
Vivek Subbiah recently posted on X: "Just published in time for the ELCC24: The Impact of…
Mar 17, 2024, 19:28 | Blog
The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 - 3P Solution
3P Solution shared a post on LinkedIn: "Great news coming up! We are organizing the…
Mar 7, 2024, 17:22 | Insight
Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Feb 1, 2024, 17:31 | Insight
Paolo Tarantino: Any agnostic approval should not stop efforts in biomarker discovery for ADCs
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: "Of…
Jan 28, 2024, 18:29 | Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
Jan 16, 2024, 01:08 | Blog
Renee Maria Saliby: Always grateful and fortunate to have David Braun's guidance
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, made the following…
Dec 29, 2023, 15:35 | Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 10, 2023, 17:26 | Career
Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "Congratulations to Mark Awad, MD, PhD who was honored…
Nov 29, 2023, 16:26 | Blog
Top 10 abstracts to keep an eye on for SABCS 23 by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "10 days to…
Nov 3, 2023, 12:19 | Insight
Omar AbdiHamid: Our study on biomarkers of Immunotherapy response
Quoting Omar AbdiHamid, Clinical Oncology Specialist at HCGCCK Cancer Centre, on LinkedIn: ''Publication Alert. Our…
Aug 17, 2023, 16:27 | Insight
Arndt Vogel: Excellent review, many open questions, Targeting cancers with KRAS-G12D mutations.
Arndt Vogel has recently shared 0n Twitter: ''Next batter up! Targeting cancers with KRAS-G12D mutations…
Aug 3, 2023, 19:14 | Opinion
The list of biomarkers to consider Precision Medicine upfront is increasing - Pashtoon Kasi
The list of biomarkers to consider Precision Medicine upfront is increasing.  Anything you’d add to…
Jul 19, 2023, 18:24 | Blog
ADCs have changed the way we treat breast cancer and there is much more to come - Guilherme Nader Marta
ADCs have changed the way we treat breast cancer and there is much more to…
Jul 9, 2023, 09:13 | Blog
Cancer patients' access to advanced genetic testing is not keeping up with the pace of discovery of targetable mutations and personalised therapies - European Society for Medical Oncology
Jun 24, 2023, 18:00 | Blog
Orion's novel approach is the future of Precision Medicine and Cancer Research - Dr. Iyad Sultan
Pathology revolutionized: The Orion Platform , breaking new ground in high-plex spatial biology, integrates traditional…
All: 39 Posts: 1 - 100
Special Coverage